Published in Clin Cancer Res on May 15, 2007
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res (2011) 2.54
Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet (2014) 1.94
The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res (2012) 1.39
Patient-derived xenografts recapitulate molecular features of human uveal melanomas. Mol Oncol (2013) 1.11
Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol (2009) 1.07
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer (2013) 1.04
Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol (2012) 1.01
A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol Biol (2014) 1.00
Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma. Mod Pathol (2011) 1.00
Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res (2014) 0.99
Molecular pathology of uveal melanoma. Eye (Lond) (2012) 0.94
Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncol Lett (2012) 0.93
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. Clin Cancer Res (2016) 0.93
FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol (2008) 0.86
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. Invest Ophthalmol Vis Sci (2012) 0.85
In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up. Graefes Arch Clin Exp Ophthalmol (2007) 0.82
Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract (2010) 0.80
Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma. Mol Vis (2013) 0.78
Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma. Oncotarget (2015) 0.78
Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc (2008) 0.78
Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices. J Cancer Res Clin Oncol (2009) 0.78
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors. PLoS One (2015) 0.78
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study. J Oncol (2016) 0.78
Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles. Biomed Microdevices (2015) 0.77
ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma. Cancer Cell (2016) 0.77
Prognostic factors of choroidal melanoma in Slovenia, 1986-2008. Radiol Oncol (2016) 0.75
Monosomy 3 by chromogenic in situ hybridization (CISH) in Iranian patients with uveal melanoma. J Curr Ophthalmol (2015) 0.75
Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. Exp Eye Res (2011) 0.75
Ciliary body melanoma - a particularly rare type of ocular tumor. Case report and general considerations. Maedica (Buchar) (2013) 0.75
The biology of uveal melanoma. Cancer Metastasis Rev (2017) 0.75
Case report: an atypical peripapillary uveal melanoma. BMC Ophthalmol (2014) 0.75
Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics. Diagn Pathol (2017) 0.75
Atypical Presentation: Metastatic Uveal Melanoma in a Young Patient without Visual Complaints. Front Oncol (2017) 0.75
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45
Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47
Pathogenesis and therapy of psoriasis. Nature (2007) 6.94
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet (2008) 5.85
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Completing the map of human genetic variation. Nature (2007) 4.38
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83
Direct genomic selection. Nat Methods (2005) 3.61
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet (2003) 3.52
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics (2003) 3.39
Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet (2002) 3.09
Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet (2010) 2.76
Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res (2011) 2.54
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn (2010) 2.48
Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet (2010) 2.41
Genomics: guilt by association. Nature (2007) 2.27
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet (2013) 2.20
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res (2007) 2.15
PSORS2 is due to mutations in CARD14. Am J Hum Genet (2012) 2.10
Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist (2011) 2.05
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res (2006) 2.03
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol (2004) 1.92
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol (2004) 1.89
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am J Hum Genet (2012) 1.88
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet (2011) 1.74
A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol (2011) 1.73
Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol (2003) 1.67
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res (2013) 1.67
Multiple Loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet (2009) 1.58
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res (2008) 1.54
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol (2011) 1.50
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol (2009) 1.50
Risk factors for metastasis in retinoblastoma. Surv Ophthalmol (2002) 1.49
Eyelid melanoma with negative sentinel lymph node biopsy and perineural spread. Arch Ophthalmol (2007) 1.46
Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol (2008) 1.44
Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab (2013) 1.42
Two novel point mutations in the long-range SHH enhancer in three families with triphalangeal thumb and preaxial polydactyly. Am J Med Genet A (2007) 1.41
Psoriasis genetics: breaking the barrier. Trends Genet (2010) 1.38
Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR. Hum Genet (2005) 1.37
Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res (2008) 1.36
New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol (2009) 1.35
DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res (2005) 1.30
A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res (2008) 1.26
A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS One (2011) 1.25
Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum Genet (2002) 1.24
Asymmetric lower-limb malformations in individuals with homeobox PITX1 gene mutation. Am J Hum Genet (2008) 1.21
Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens. J Mol Diagn (2006) 1.20
Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Ophthalmol (2005) 1.19
Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res (2008) 1.18
Nondiagnosed uveal melanomas. Ophthalmology (2004) 1.15
Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol (2005) 1.14
A transmission disequilibrium test for general pedigrees that is robust to the presence of random genotyping errors and any number of untyped parents. Eur J Hum Genet (2004) 1.13
Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol (2014) 1.13
Patient-derived xenografts recapitulate molecular features of human uveal melanomas. Mol Oncol (2013) 1.11
Fine needle aspiration biopsy with adjunct immunohistochemistry in intraocular tumor management. Acta Cytol (2005) 1.10
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet (2012) 1.10
Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. Invest Ophthalmol Vis Sci (2005) 1.08
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer (2013) 1.04
Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. J Invest Dermatol (2008) 1.04
Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J Invest Dermatol (2011) 1.04
Psoriasis genetics: the way forward. J Invest Dermatol (2004) 1.03
Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina (2011) 1.03
Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J (2011) 1.03
Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med (2002) 1.02
Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res (2012) 1.01
Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol (2012) 1.01
Molecular genetics of uveal melanoma. Curr Eye Res (2003) 1.00
Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res (2014) 0.99
Rb at the interface between cell cycle and apoptotic decisions. Curr Mol Med (2006) 0.98
Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina (2014) 0.98
Carriers of rare missense variants in IFIH1 are protected from psoriasis. J Invest Dermatol (2010) 0.97
Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J Biol Chem (2003) 0.97
HOXD10 M319K mutation in a family with isolated congenital vertical talus. J Orthop Res (2006) 0.96
SNTG1, the gene encoding gamma1-syntrophin: a candidate gene for idiopathic scoliosis. Hum Genet (2004) 0.96
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunol Immunother (2014) 0.96
Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care (2003) 0.96